Assoc Prof Dr. Evelin Andrade Manoe| Biotechnology|Best Researcher Award

Published on by Top Pharmaceutical

Assoc Prof Dr. Evelin Andrade Manoe, Biotechnology,Best Researcher Award

Prof. Evelin Andrade Manoe, at Universidade Federal do Rio de Janeiro,Brazil

PROFILE

scopus
Google Scholar 

Formal Education🎓

Doctorate in Chemical Engineering
Universidade Federal do Rio de Janeiro, UFRJ, Rio De Janeiro, Brazil
2011 – 2014

  • Title: Obtenção de Biocatalisador para Resolução Cinética de Derivados farmacológicos de mio-Inositol (Obtaining a Biocatalyst for Kinetic Resolution of Pharmaceutical Derivatives of myo-inositol)
  • Advisors: Maria Alice Zarur Coelho and Denise Maria Guimarães Freire
  • Scholarship: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil

Master’s in Chemical Engineering
Universidade Federal do Rio de Janeiro, UFRJ, Rio De Janeiro, Brazil
2009 – 2011

  • Title: Resolução de derivados racêmicos de myoinositol catalisados por lipases (Resolution of racemic myoinositol derivatives catalyzed by lipases)
  • Advisors: Denise Maria Guimarães Freire and Maria Alice Zarur Coelho
  • Scholarship: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do RJ (FAPERJ), Brazil

Graduation in Biological Sciences Education
Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
2006 – 2013

  • Scholarship: National Council for Scientific and Technological Development (CNPq), Brazil

Bachelor’s Degree in Biological Sciences
Federal University of Rio de Janeiro, UFRJ, Rio De Janeiro, Brazil
2006 – 2008

  • Title: The genus Strychnos L. in the state of Rio de Janeiro
  • Advisor: Elsie Franklin Guimarães
  • Scholarship: National Council for Scientific and Technological Development (CNPq), Brazil

Technical Education in Industrial Chemistry
Federal Center for Technological Education in Chemistry of Nilópolis/RJ (CEFETEQ), Brazil
2005 – 2008

Complementary Education🏥

  • 2005: Short Term Course in Bioquímica de Plantas (8h), Universidade Estadual de Campinas, UNICAMP, Campinas, Brazil
  • 2005: Short Term Course in Células Tronco e Terapia Gênica (8h), Universidade Estadual de Campinas, UNICAMP, Campinas, Brazil
  • 2007: Short Term Course in Fundamentos e Aplicações da RMN (10h), Universidade Federal do Rio de Janeiro, UFRJ, Rio De Janeiro, Brazil
  • 2008: Short Term Course in Química Forense (10h), Universidade Federal do Rio de Janeiro, UFRJ, Rio De Janeiro, Brazil
  • 2008: Short Term Course in Técnicas Espectroscópicas Avançadas (10h), Universidade Federal do Rio de Janeiro, UFRJ, Rio De Janeiro, Brazil
  • 2009: Short Term Course in Planejamento Experimental e Otimização de Processo (45h), Universidade Federal do Rio de Janeiro, UFRJ, Rio De Janeiro, Brazil
  • 2012: Short Term Course in Introdução a Biocatálise (18h), Universidade Federal do Rio de Janeiro, UFRJ, Rio De Janeiro, Brazil
  • 2012: Short Term Course in Advanced Course Biocatalysis (80h), Delft University of Technology, Netherlands, TU DELFT, Netherlands (Scholarship: CNPq, Brazil)
  • 2012: Short Term Course in IX Curso Latinoamericano de Biotecnología (48h), Pontificia Universidad Católica de Valparaiso, Chile, PUC-VALPARAISO, Chile (Scholarship: CNPq, Brazil)

Professional Experience📚

Universidade Federal do Rio de Janeiro – UFRJ
2014 – Current: Associate Professor

  • Undergraduate subjects taught: Pharmaceutical Biotechnology (FFM 426), Fermentation Technology (FFI 428), Biocatalysts in Industrial Processes (FFI013)
  • Postgraduate subjects: Immobilized Biocatalysts (FFF737), Advanced Pharmaceutical Biotechnology (FFF721), Industrial Obtaining of Bioproducts (CTF715), Seminars I, Seminars II, Special Topics in Biotechnology: Enzymology

2014 – 2016: Department Boss in Pharmaceutical Biotechnology

2012 – 2013: Substitute Professor

  • Working hours: 20 hours/week
  • Institution: Universidade Federal do Rio de Janeiro

2008 – 2008: Basic Biochemistry Monitoring

  • Institution: Universidade Federal do Rio de Janeiro

Instituto de Pesquisa Jardim Botânico do Rio de Janeiro – JBRJ
2005 – 2009: PIBIC/CNPq scholarship holder

Research and Technological Projects🏆

2024 – Current: Petrobras Project: Desenvolvimento de um método de avaliação de produtos químicos usados na remoção de incrustações de sulfatos de bário e estrôncio na produção de petróleo (Development of a method for evaluating chemicals used in the removal of barium and strontium sulfate scale in oil production)

2023 – Current: Petrobras Project: Síntese e Avaliação de Desempenho de Potenciais Inibidores Verdes Resistentes a Altas Temperaturas Destinados à Inibição de Incrustação Inorgânica (Synthesis and Performance Evaluation of Potential High Temperature Resistant Green Inhibitors for Inorganic Scale Inhibition)

 

 

🎓Publication 

Growing knowledge: an overview of seed plant diversity in Brazil

  • Authors   :BFG-The Brazil Flora Group, Daniela C Zappi, Fabiana L Ranzato Filardi, Paula
  • Journal    :nstituto de Pesquisas Jardim Botânico do Rio de Janeiro
  • Year         :2015

Immobilization of lipases on hydrophobic supports involves the open form of the enzyme

    • Authors :Evelin A Manoel, José CS Dos Santos, Denise MG Freire, Nazzoly Rueda, Roberto Fernandez-Lafuente
    • Journal   :Enzyme and Microbial Technology
    • Year       : 2015

Nanomaterials for biocatalyst immobilization–state of the art and future trends

  • Authors  :Eliane P Cipolatti, Alexsandra Valerio, Rosana O Henriques, Denise E Moritz, Jorge L Ninow, Denise MG Freire,
  • Journal    :RSC advances
  • Year         :  2016

Accurel MP 1000 as a support for the immobilization of lipase from Burkholderia cepacia: application to the kinetic resolution of myo-inositol derivatives

  • Authors  :Evelin A Manoel, Marcela FP Ribeiro, Jose CS Dos Santos, Maria Alice Z Coelho,
  • Journal   :Process Biochemistry
  • Year        :   2015

Preparation of core–shell polymer supports to immobilize lipase B from Candida antarctica: effect of the support nature on catalytic properties

  • Authors  :Aline G Cunha, Marina D Besteti, Evelin A Manoel, Angelo AT da Silva, Rodrigo V Almeida, Alessandro BC Simas, Roberto Fernandez-Lafuente, José Carlos Pinto, Denise MG Freire
  • Journal   :Journal of Molecular Catalysis B: Enzymatic
  • Year        :  2014

Dr. Jinat Alam| Clinical Trials|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Jinat Alam, Clinical Trials,Best Researcher Award

Dr. Jinat Alam, at icddr,b,Bangladesh

PROFILE

scopus

Orcid

Google Scholar 

🎓Early Academic Pursuits :

Dr. Jinat Alam embarked on her academic journey with a Bachelor of Medicine, Bachelor of Surgery (MBBS) from the University of Dhaka, Bangladesh. She completed her MBBS from Ibn Sina Medical College and Hospital in June 2014 with an overall GPA of 3.00 (WES Evaluation). Her passion for public health led her to pursue a Master’s in Public Health (MPH) from North South University, Bangladesh, where she excelled with an impressive GPA of 3.83 out of 4.00, completing the program in March 2024. Her major courses included Epidemiology, Biostatistics, Research Methodology, and Health System and Management, which laid a strong foundation for her future endeavors in the field of public health.

🏥Professional Endeavors :

Dr. Alam’s professional journey is marked by significant roles and contributions in various capacities at icddr,b, an international health research institution based in Bangladesh. She began her career as a Clinical Fellow at icddr,b, from March 2017 to August 2019, where she maintained regular hospital patient care and participated in clinical duties in Pediatrics and Internal Medicine under the Nutrition and Clinical Services Division. Her responsibilities included addressing Gastrointestinal Diseases, Tuberculosis and Lung Diseases, Maternal and Child Nutrition, and Critical Care.

From September 2019 to November 2023, she served as a Project Research Physician, leading randomized controlled clinical trials and presenting her findings at various scientific forums. Currently, she holds the position of Study Physician at icddr,b, where she continues to contribute to research protocol writing, protocol development, and community trials.

📚Contributions and Research Focus :

Dr. Alam’s research focus spans a wide range of public health issues, particularly in the areas of malnutrition, environmental enteric dysfunction, and complementary food development. She has been involved in several pivotal research projects, including:

  • Efficacy Trial of Microbiota Directed Food on Children with Moderate Acute Malnutrition (Co-Investigator, PR-24031, NCT06305442)
  • Assessment of Body Composition in Bangladeshi Children and Validation of Skinfold Thickness-Based Body Composition Prediction Equations (Principal Investigator, PR-24007)
  • Role of L-Carnitine Supplementation on Rate of Weight Gain and Biomarkers of Environmental Enteric Dysfunction in Children with Severe Acute Malnutrition (Principal Investigator, PR-21046, NCT05083637)
  • Development of Shelf-Stable, Locally-Sourced, Microbiota-Directed Complementary Foods for Children with Undernutrition (Study Physician, PR-21019)
  • A Bayesian approach to predict the role of dietary diversity, water, sanitation and hygiene practice, enteric infections and impaired gut health on multiple micronutrient deficiencies in children at 24 months of age (Project Research Physician, PR-20051)
  • Zinc sulfate acceptability study in children with acute diarrhea (Project Research Physician, PR-19033, NCT04039828)

🏆Accolades and Recognition :

Dr. Alam’s dedication and excellence in research have been recognized through various awards. She received the ‘Young Scientist Award’ under the ‘Rainy Day grant fund’ of icddr,b, a competitive research grant of $25,000 for a duration of one year. Additionally, her outstanding performance in oral presentations earned her the ‘Best Presenter Award’ at the Executive Director’s Scientific Seminar in 2023.

🌍Impact and Influence :

Dr. Alam’s work has had a profound impact on the field of public health in Bangladesh and beyond. Her research on malnutrition and environmental enteric dysfunction has contributed to a better understanding of these critical issues and has paved the way for developing effective interventions. Her involvement in clinical trials and research projects has influenced public health policies and practices, benefiting countless children and communities.

🌟Legacy and Future Contributions :

Dr. Alam’s legacy is defined by her relentless pursuit of excellence in public health research and her commitment to improving the lives of vulnerable populations. Her work at icddr,b and her contributions to various research projects have set a high standard for future public health professionals. As she continues her journey, Dr. Alam aims to further her research on malnutrition, develop innovative solutions for public health challenges, and mentor the next generation of public health researchers.

📝Conclusion :

Dr. Jinat Alam’s journey is a testament to her dedication, expertise, and impact in the field of public health and medicine. Her early academic pursuits, professional endeavors, research contributions, accolades, and future aspirations highlight her as a distinguished figure in her field. Her legacy will continue to inspire and influence public health initiatives, making a lasting difference in the lives of many.

🎓Publication 

Inadequate vitamin C intake and intestinal inflammation are associated with multiple micronutrient deficiency in young children: results from a multi-country birth cohort study

  • Authors   :Shah Mohammad Fahim, Md Ashraful Alam, Jinat Alam, Md Amran Gazi, Mustafa Mahfuz, Tahmeed Ahmed.
  • Journal    :Nutrients
  • Year         :2022

Role of L-Carnitine supplementation on rate of weight gain and biomarkers of Environmental Enteric Dysfunction in children with severe acute malnutrition: A protocol for a …

    • Authors :Jinat Alam, Md Ridwan Islam, Shah Mohammad Fahim, Md Amran Gazi, Tahmeed Ahmed
    • Journal   :Plos one
    • Year       : 2022

Effects of L-Carnitine Supplementation on the Rate of Weight Gain and Biomarkers of Environmental Enteric Dysfunction in Children with Severe Acute Malnutrition: A Double-Blind …

  • Authors  :Jinat Alam, Shah Mohammad Fahim, Md Ridwan Islam, Md Ashraful Alam, Md Amran Gazi, Tahmeed Ahmed
  • Journal    :The Journal of Nutrition
  • Year         :  2024

Nutritional profiles and zinc supplementation among children with diarrhea in Bangladesh

  • Authors  :Jinat Alam, Sharika Nuzhat, Shebab Md Billal, Tahmeed Ahmed, Azharul Islam Khan, Md Iqbal Hossain
  • Journal   :The American Journal of Tropical Medicine and Hygiene
  • Year        :   2023

New formulation zinc sulphate acceptability and adherence in children with acute diarrhoea: a prospective, open‐label, interventional study in Bangladesh

  • Authors  :Sharika Nuzhat, Tahmeed Ahmed, Jinat Alam, Shebab Md Billal, Azharul Islam Khan, Md Iqbal Hossain
  • Journal   :Journal of Paediatrics and Child Health
  • Year        :  2022

Dr. Duduzile Ndwandwe| Clinical Trials|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Duduzile Ndwandwe, Clinical Trials,Best Researcher Award

Dr. Duduzile Ndwandwe, at Cochrane South Africa, South African Medical Research Council,South Africa

PROFILE

scopus

 

🎓Early Academic Pursuits :

Duduzile Ndwandwe was born in Waterval Boven, Mpumalanga, South Africa. Her academic journey began at Sikhulile Secondary School, where she completed her Matric Senior Certificate in 2001. She then pursued higher education at the University of Limpopo, earning a Bachelor of Science degree in 2006 with majors in Physiology and Microbiology. Following this, she completed her Bachelor of Science Honours in Microbiology in 2007. Her passion for scientific research and dedication to advancing her knowledge led her to the University of the Witwatersrand, where she obtained a Master of Science in Microbial Genetics in 2008. She continued her studies at the same institution, earning a PhD in Molecular Mycobacteriology in 2013. Duduzile further expanded her expertise with an International Masters in Vaccinology from the University of Lausanne in 2021 and an Advanced Vaccinology Course from the University of Geneva in 2022. In 2023, she completed a Management Development Programme at Stellenbosch University.

🏢Professional Endeavors :

Duduzile Ndwandwe’s professional career is marked by significant contributions to the fields of vaccinology and public health. She began her career as a Laboratory Assistant at the University of Limpopo in 2006 and then served as a Teaching Assistant at the University of the Witwatersrand in 2007. Her postdoctoral journey took her to the University of KwaZulu-Natal, where she worked as a Postdoctoral Research Fellow in the Department of Pharmacology from 2015 to 2016.

In 2013, Duduzile joined the South African Medical Research Council (SAMRC) as a Senior Scientist in the HIV Prevention Research Unit, a role she held until 2015. She then transitioned to the Wits Reproductive Health & HIV Institute as a Senior Researcher, where she led clinical trials such as HPTN 082 and EMPOWER from 2016 to 2017. Since 2021, Duduzile has been a Specialist Scientist at Cochrane South Africa, leading projects on Vaccine Implementation Research and Clinical Trial Registration. She also served as the Deputy Director of Cochrane South Africa from 2021 to 2024 and has been the Board Chair of Eh! Woza since 2019.

🔬Contributions and Research Focus :

Duduzile Ndwandwe’s research primarily focuses on vaccinology, clinical trials, and public health. She has been instrumental in leading and facilitating numerous projects that aim to improve vaccination implementation and clinical trial methodologies in Africa. Her work includes significant contributions to the South African National Clinical Trial Register and the Pan African Clinical Trial Register (PACTR). She has also been involved in projects funded by prominent organizations such as the National Research Foundation, EDCTP, and Oxford University, addressing critical health issues and enhancing research capacities in the region.

🏆Accolades and Recognition :

Duduzile’s outstanding contributions to science and public health have been recognized through various awards and scholarships. Notable among these are the International Masters in Vaccinology program scholarship from SAMRC (2018-2021) and the postdoctoral research scholarship from the University of KwaZulu-Natal in 2015. She was also a recipient of the prestigious Columbia University – Southern African Fogarty AIDS Training and Research Programme fellowship in 2010 and the Mellon Postgraduate Mentoring Scheme scholarship from the University of the Witwatersrand (2009-2011).

🌍Impact and Influence :

Throughout her career, Duduzile Ndwandwe has significantly impacted the scientific community and public health sector. Her research has led to improved methodologies in clinical trials and vaccination programs, enhancing transparency and accountability in clinical trial registrations across Africa. Her leadership roles in various research initiatives and institutions have fostered collaborations and capacity-building, driving progress in public health and vaccinology.

🔮Legacy and Future Contributions :

Duduzile Ndwandwe’s legacy is defined by her unwavering commitment to advancing scientific research and public health. Her work has laid the foundation for future research and interventions in vaccinology and clinical trials. She continues to influence upcoming scientists and public health professionals through her mentorship and leadership roles. As she progresses in her career, Duduzile remains dedicated to addressing global health challenges and contributing to the betterment of public health systems worldwide.

🎓Publication 

High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis

  • Authors   :Mabhida, S.E., Mchiza, Z.J., Mokgalaboni, K., … Kengne, A.P., Dludla, P.V.
  • Journal    :MC Infectious Diseases
  • Year         :2024

The impact of DNA methylation as a factor of Adverse Pregnancy and Birth Outcomes (APBOs): a systematic review protocol

    • Authors :Moagi, I., Mabasa, L., Maputle, S.M., … Malwela, T., Samie, A.
    • Journal   :Systematic Reviews
    • Year       : 2024

Global trends in clinical trials and interventions for the metabolic syndrome: A comprehensive analysis of the WHO International Clinical Trials platform

Peer learning in immunisation programmes

  • Authors  :Adamu, A.A., Ndwandwe, D., Jalo, R.I., Ndoutabe, M., Wiysonge, C.S.
  • Journal   :The Lancet
  • Year        :   2024

Cofinancing immunisation through national health insurance

Dr. Khaled Allemailem| Vaccine Development|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Khaled Allemailem,Vaccine Developmen,Best Researcher Award

Dr. ANTHOULA LAZARIS, at Qassim University,Saudi Arabia

PROFILE

scopus

Orcid

Google scholar

📚Early Academic Pursuits :

Khaled Saleh A. Allemailem began his academic journey at King Saud University, Qassim Branch, where he obtained a Bachelor’s degree in Medical Microbiology from 1998 to 2002. His passion for medical sciences led him to pursue advanced studies at RMIT University in Australia. He earned his Master of Laboratory Medicine from the School of Medical Sciences in July 2010 and subsequently completed a Graduate Diploma in Biotechnology from the School of Applied Sciences in December 2010. Khaled furthered his expertise by attaining a PhD in Microbiology from RMIT University in August 2016, with his thesis titled “Colonisation and Virulence Characteristics of Campylobacter concisus Oral and Clinical Strains.”

💼Professional Endeavors :

Khaled’s professional journey is marked by diverse roles in both academic and medical settings. He commenced his career as a teacher in the Ministry of Education, Saudi Arabia, from July 2003 to May 2007. He then transitioned to Qassim University, where he served as a Teaching Assistant in the Department of Medical Laboratories from May 2007 to February 2013. His dedication to education and research led to his promotion as a Lecturer in February 2013, and subsequently as an Assistant Professor in December 2016. In June 2021, Khaled was appointed Associate Professor, a position he currently holds. His teaching portfolio includes courses such as Clinical Bacteriology, Applied Microbiology, Research Methodology, and Medical Terminology.

🔬Contributions and Research Focus :

Khaled’s research primarily revolves around microbiology, with a specific focus on bacterial colonization, virulence, and antibiotic resistance. His doctoral thesis investigated the colonization and virulence characteristics of Campylobacter concisus, contributing valuable insights to the field. His hands-on expertise in PCR, SDS-PAGE, cloning, bacterial isolation, and characterization is complemented by proficiency in software like Clone Manager, MacVector, and Prism. Khaled has supervised master’s theses on topics such as the biogenic synthesis and antibacterial activity of zinc oxide nanoparticles and the prevalence and phylogenetic analysis of antibiotic-resistant bacterial isolates.

🏅Accolades and Recognition :

Throughout his career, Khaled has been recognized for his significant contributions to microbiology and medical education. His registration as a Consultant in Medical Microbiology by the Saudi Commission for Health Specialties (SCHS) is a testament to his expertise and professional standing. His work has not only advanced scientific understanding but also had a practical impact on healthcare practices, particularly in combating antibiotic resistance.

🌍Impact and Influence :

Khaled’s influence extends beyond his research contributions. As an educator, he has shaped the academic journeys of numerous students at Qassim University. His involvement in teaching both undergraduate and postgraduate courses has been instrumental in nurturing the next generation of medical laboratory scientists. Khaled’s commitment to student supervision, exemplified by his guidance of master’s students, underscores his dedication to academic mentorship and research excellence.

🌟Legacy and Future Contributions :

Khaled Saleh A. Allemailem’s legacy is characterized by his dual impact as a researcher and educator. His work in microbiology has contributed to the global understanding of bacterial colonization and antibiotic resistance, while his role as a professor has enriched the academic fabric of Qassim University. Looking ahead, Khaled is poised to continue his contributions to the field through ongoing research, student mentorship, and collaborative projects. His vision for the future includes expanding his research on microbial pathogenesis and exploring innovative solutions to emerging challenges in medical microbiology.

🎓Publication 

Implications of green tea and its constituents in the prevention of cancer via the modulation of cell signalling pathway

  • Authors   :Arshad H Rahmani, Fahad M Al Shabrmi, Khaled S Allemailem, Salah M Aly, Masood A Khan
  • Journal    :BioMed Research International
  • Year         :2015

The biochemical and clinical perspectives of lactate dehydrogenase: an enzyme of active metabolism

    • Authors :Amjad A Khan, Khaled S Allemailem, Fahad A Alhumaydhi, Sivakumar JT Gowder, Arshad H Rahmani
    • Journal   :Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)
    • Year       : 2020

Potential therapeutic targets of quercetin, a plant flavonol, and its role in the therapy of various types of cancer through the modulation of various cell signaling pathways

  • Authors  :,Saleh A Almatroodi, Mohammed A Alsahli, Ahmad Almatroudi, Amit Kumar Verma, Abdulaziz Aloliqi, Khaled S Allemailem, Amjad Ali Khan, Arshad Husain Rahmani
  • Journal    :Molecules
  • Year         :  2021

Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications

  • Authors  :Amjad Ali Khan, Khaled S Allemailem, Saleh A Almatroodi, Ahmed Almatroudi, Arshad Husain Rahmani
  • Journal   :3 Biotech
  • Year        :   2020

Bioinspired Green Synthesis of Zinc Oxide Nanoparticles from a Native Bacillus cereus Strain RNT6: Characterization and Antibacterial Activity against Rice Panicle Blight Pathogens …

  • Authors  :Rada, M., Krzywon, L., Petrillo, S., Lazaris, A., Metrakos, P.
  • Journal   : Nanomaterials
  • Year        :  2021

Dr. ANTHOULA LAZARIS| Precision Medicine|Best Researcher Award

Published on by Top Pharmaceutical

Dr. ANTHOULA LAZARIS, Precision Medicine,Best Researcher Award

Dr. ANTHOULA LAZARIS, at MCGILL UNIV. HEALTH CTR,Canada

PROFILE

scopus

📚 Early Academic Pursuits :

Anthoula Lazaris began her academic journey with a B.Sc. in Microbiology and Immunology from McGill University (1983-1986), where she developed a solid foundation in the biological sciences. She continued at McGill, earning a Ph.D. in Biochemistry from the Faculty of Medicine (1988-1992). Her postdoctoral studies took her to Leiden, The Netherlands, where she further honed her expertise in Medical Biochemistry (1992-1994). This robust educational background laid the groundwork for her illustrious career in academia and biotechnology.

🏢Professional Endeavors :

Lazaris has accumulated over 30 years of combined experience in academia and industry, holding management and senior-level positions. Currently, she is a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), focusing on metastatic and metabolic diseases with an emphasis on translational research. Her career highlights include:

  • Liver Disease Biobank: In 2011, Lazaris established a Liver Disease Biobank in collaboration with Dr. P Metrakos, collecting biospecimens from patients with liver-related diseases.
  • Quebec Extracellular Vesicle Consortium: She spearheaded this consortium with Drs. Rak and Olivier, demonstrating her leadership in collaborative research initiatives.
  • CIHR Training Grant: Lazaris co-wrote and secured a substantial CIHR training grant for the Goodman Cancer Centre, illustrating her proficiency in obtaining competitive funding.

🔬Contributions and Research Focus :

Lazaris’s research contributions span several critical areas:

  • Metastatic Disease: She focuses on colorectal cancer liver metastases (CRCLM), investigating molecular mechanisms to predict therapeutic responses and developing new biomarkers.
  • Translational Research: Her work bridges basic and clinical research, aiming to translate findings into precision therapies for cancer patients. Notably, her research on predictors of therapeutic responses to antiangiogenic agents has been groundbreaking.
  • Liver Diseases: Lazaris’s research also covers hepatocellular carcinoma, cholangiocarcinomas, and NAFLD/NASH, contributing to the broader understanding of these conditions.

🏆Accolades and Recognition :

Throughout her career, Lazaris has received numerous accolades:

  • Scientific American Award: In 2002, she was recognized in the category of Research Leader in Chemical and Materials for her work on transgenic animals producing spider silk.
  • Genome Canada White Paper: She spearheaded the writing of a white paper on “Disease Mechanisms,” which was integrated into Genome Quebec’s strategic plan.
  • Scientific Publications: Her research has been published in prestigious journals like Nature and Science, highlighting her contributions to molecular biology and oncology.

🌍Impact and Influence :

Lazaris’s work has had a profound impact on both the scientific community and public health:

  • Innovations in Biotechnology: She was part of the team that demonstrated the first expression of soluble spider silk, which can be spun into fibers with remarkable mechanical properties.
  • Transgenic Research Network: As the Executive Director of the Quebec Transgenic Research Network, Lazaris unified the capabilities of researchers across Quebec, securing significant funding and fostering collaborative research.
  • Cloned Animals: She was part of the team that generated the world’s first cloned goat and Canada’s first large transgenic animal, showcasing her pioneering contributions to genetic engineering.

🌟Legacy and Future Contributions :

Anthoula Lazaris’s legacy is marked by her pioneering research, leadership in collaborative scientific endeavors, and significant contributions to translational medicine. Her work continues to influence the fields of molecular biology, biotechnology, and cancer research. Looking forward, Lazaris is expected to further her contributions to personalized medicine, leveraging her extensive experience and innovative approach to address pressing challenges in healthcare. Her dedication to translational research and collaborative spirit ensures that her impact will be felt for years to come.

🎓Publication 

Predictive biomarker discovery in cancer using a unique AI model based on set theory

Hepatic stellate cell stearoyl co-A desaturase activates leukotriene B4 receptor 2 – β-catenin cascade to promote liver tumorigenesis

    • Authors :Sinha, S., Aizawa, S., Nakano, Y., … Guccione, E., Tsukamoto, H.
    • Journal   :Nature Communications
    • Year       : 2023

Targeting Liver Metastases to Potentiate Immunotherapy in MS-Stable Colorectal Cancer—A Review of the Literature

  • Authors  :, Zlotnik, O., Krzywon, L., Bloom, J., … Lazaris, A., Metrakos, P.
  • Journal    :Cancers
  • Year         :  2023

Isolation of extracellular vesicles from human plasma samples: The importance of controls

  • Authors  :Tsamchoe, M., Petrillo, S., Lazaris, A., Metrakos, P.
  • Journal   : Biotechnology Journal
  • Year        :   2023

A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases

  • Authors  :Rada, M., Krzywon, L., Petrillo, S., Lazaris, A., Metrakos, P.
  • Journal   : Biotechnology 
  • Year        :  2023

Ms. Ara Cho| Biomarker Research|Best Researcher Award

Published on by Top Pharmaceutical

Ms. Ara Cho, Biomarker Research,Best Researcher Award

Ms. Ara Cho, at Seoul National University,South Korea

PROFILE

GOOLE scholar

🎓Early Academic Pursuits :

Ara Cho embarked on her academic journey at The Catholic University of Korea, where she pursued a Bachelor’s degree in Biology from the Department of Life Science and Environment. From March 2015 to February 2019, she dedicated herself to understanding the fundamental principles of biology, earning a B.S. in Biology with commendable academic performance. Her undergraduate years were marked by a growing interest in analytical chemistry and proteomics, which set the stage for her future research endeavors.

In September 2019, Ara Cho continued her academic pursuits at Seoul National University, enrolling in the Ph.D. program in the Department of Molecular Medicine and Biopharmaceutical Sciences. Her rigorous coursework and research in this program have been driven by a profound interest in mass spectrometry-based proteomics and translational bioinformatics. Maintaining an impressive GPA of 4.1/4.3, Ara has demonstrated exceptional academic prowess and a commitment to advancing scientific knowledge.

👩‍🔬Professional Endeavors :

Ara Cho’s professional journey is distinguished by a series of impactful research experiences and collaborations. She served as a research intern at the Graduate School of Convergence Science and Technology at Seoul National University from January 2018 to December 2018. This experience honed her skills in proteomics and data analysis, providing a solid foundation for her future research projects.

Subsequently, she continued as a research intern at the Department of Molecular Medicine and Biopharmaceutical Sciences at Seoul National University from March 2019 to August 2019. Her internship experiences allowed her to work on cutting-edge research projects, further deepening her expertise in proteomics and biomarker discovery.

From November 2022 to April 2023, Ara expanded her research horizons internationally as a researcher at the Fred Hutchinson Cancer Research Center in Seattle, United States. This position enabled her to collaborate with leading scientists and gain exposure to advanced research methodologies and technologies, significantly enriching her research portfolio.

🔬Contributions and Research Focus :

Ara Cho’s research is characterized by its focus on analytical chemistry, mass spectrometry-based proteomics, data analysis, machine learning, and translational bioinformatics. Her work aims to develop innovative biomarker panels and diagnostic strategies to improve disease prediction and treatment outcomes. Notable among her contributions are her publications in high-impact journals and her involvement in significant research projects.

Her research publications include:

  1. Proteomics Analysis of FFPE Tissue Sections: This study, published in Rapid Communications in Mass Spectrometry (2023), highlights Ara’s expertise in proteomics and her innovative use of isobaric-tag amplification for individual tissue sections.
  2. Multi-Biomarker Panel for Rheumatoid Arthritis: Published in Translational Research (2024), this research identifies biomarkers for predicting the response to Tocilizumab in rheumatoid arthritis patients, showcasing her translational bioinformatics skills.
  3. Refinement of Spectral Counting in Quantitative Proteomics: This work, published in Expert Review of Proteomics (2024), addresses limitations in spectral counting and enhances accuracy, reflecting Ara’s commitment to advancing proteomics methodologies.
  4. Neddylation of Insulin Receptor Substrate: Published in Cancer Gene Therapy (2024), this study explores the implications of insulin signaling in cancer cell migration, underlining her interdisciplinary research approach.
  5. TNF-α Modulation in Breast Cancer Cells: Featured in Cancer & Metabolism (2021), this research investigates the differential modulation of mitochondrial complex activity in breast cancer cells, emphasizing her contributions to cancer biology.

🏅Accolades and Recognition :

Ara Cho’s dedication and contributions to the field of proteomics have been recognized through various accolades and invitations to present her research at prestigious conferences. Noteworthy among her conference presentations are:

  1. Transformative Proteomics for Precision Medicine: An oral presentation at KHUPO Virtual Conference, Korea (September 2020), where she discussed the impact of proteomics on precision medicine.
  2. International Conference KSMCB 2020: A poster presentation at KSMCB Virtual Conference, Korea (October 2020), where she showcased her innovative research findings.
  3. 10th Asia-Oceania Human Proteome Organization Congress: An oral presentation in Busan, Korea (June 2021), highlighting her contributions to proteomics.
  4. 71st Conference on Mass Spectrometry and Allied Topics: A poster presentation in Texas, United States (June 2023), demonstrating her international research impact.

Impact and Influence 

Ara Cho’s research has had a profound impact on the field of proteomics and translational bioinformatics. Her work on biomarker discovery and diagnostic strategies has the potential to revolutionize personalized medicine, particularly in the context of autoimmune diseases and cancer. By integrating mass spectrometry with machine learning and bioinformatics, she has contributed to the development of predictive models and diagnostic tools that enhance treatment precision and patient outcomes.

🚀Legacy and Future Contributions :

Ara Cho’s legacy lies in her relentless pursuit of scientific excellence and her contributions to advancing proteomics research. Her innovative approaches and interdisciplinary research have paved the way for future discoveries in biomarker identification and disease diagnostics. As she continues her Ph.D. studies and beyond, Ara is poised to make further significant contributions to the scientific community, driving forward the fields of analytical chemistry, proteomics, and translational bioinformatics.

🎓Publication 

TNF-α differentially modulates subunit levels of respiratory electron transport complexes of ER/PR+ ve/− ve breast cancer cells to regulate mitochondrial complex activity and …

  • Authors   :Anjali Shinde, Hyeryeon Jung, Hayun Lee, Kritarth Singh, Milton Roy, Dhruv Gohel, Han Byeol Kim, Minal Mane, Hitesh Vasiyani, Fatema Currim, Yu Ri Seo, Seojin Yang, Ara Cho, Eugene C Yi, Rajesh Singh
  • Journal    :Cancer & Metabolism
  • Year         : 2021

Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migration

    • Authors :Jun Bum Park, Geon Ho Moon, Ara Cho, Minji Kwon, Jong-Wan Park, Eugene C Yi, Haeryoung Kim, Junji Fukuda, Cheol Kwak, Young-Gyu Ko, Yang-Sook Chun
    • Journal   :Cancer Gene Therapy
    • Year       :

A Multi-Biomarker Panel for Predicting Tocilizumab Response in Rheumatoid Arthritis Patients

  • Authors  :, Ara Cho, Jinsung Ahn, Andrew Kim, Yun Jong Lee, Yeong Wook Song, Yoshiya Tanaka, C Yi Eugene
  • Journal    :Translational Research
  • Year         :  2024

Proteomics analysis of an individual formalin‐fixed paraffin‐embedded tissue section using isobaric‐tag amplification

  • Authors  :Ara Cho, Jinsung Ahn, Andrew Kim, Jeong Hyun Lee, Han Suk Ryu, Kristine M Kim, Eugene C Yi
  • Journal   :Rapid Communications in Mass Spectrometry
  • Year        :   2023

 

 

Assist Prof Dr. Ali Tavakoli|Oncology Pharmaceuticals|Best Researcher Award-1234

Published on by Top Pharmaceutical

Assist Prof Dr. Ali Tavakoli,Oncology Pharmaceutical,Best Researcher Award

Assist Prof Dr. Ali Tavakoli, at Shiraz University of Medical Sciences,Iran

PROFILE

GOOLE scholar

🎓Early Academic Pursuits :

Dr. Ali Tavakoli embarked on his distinguished academic journey by earning his Medical Doctor (MD) degree from Shiraz University of Medical Sciences in Shiraz, Iran, in 1998. His early academic pursuits were marked by a profound interest in the complexities of the human body and the desire to contribute to medical science. This foundational phase was not just about acquiring knowledge but also about laying the groundwork for a career dedicated to improving health outcomes.

He continued his academic journey with a Master in Public Health (MPH) from the same institution in 2007. His MPH thesis, which focused on investigating risk factors of low birth weight in newborns, underlined his commitment to addressing public health issues. The meticulous work conducted under the supervision of Dr. Mohammad Hadi Imanieh showcased his analytical skills and dedication to maternal and child health.

🩺Professional Endeavors :

Dr. Tavakoli’s professional career has been a blend of clinical practice, administrative roles, and academic contributions. As an Assistant Professor in the Department of Persian Medicine at Shiraz University of Medical Sciences, he has been instrumental in advancing the field of traditional medicine. His role involves not only teaching but also mentoring students and conducting groundbreaking research.

Between May 2020 and November 2021, he served as the Advisor to the Chancellor of Shiraz University of Medical Sciences, a role that emphasized his leadership and strategic planning abilities. His involvement in significant projects, such as the national food security project in Zarrin Dasht County and the national MMR vaccination project, highlights his dedication to public health initiatives.

📚Contributions and Research Focus :

Dr. Tavakoli’s research has significantly contributed to various fields, including traditional Persian medicine, public health, and clinical trials. His Ph.D. thesis, supervised by Dr. Seyed Alireza Taghavi, evaluated the effect of Rose (Rosa damascena mill L) Oil Soft Capsules on clinical outcomes in ulcerative colitis, showcasing his innovative approach to integrating traditional remedies with modern clinical practices.

His extensive list of publications, including studies on the quality of work life and human resource productivity, the effects of medicinal plants on clinical conditions, and the efficacy of traditional treatments, reflects his diverse research interests and his ability to bridge traditional and modern medicine. Notable publications include:

  • “Efficacy of Rose Oil Soft Capsules on Clinical Outcomes in Ulcerative Colitis: A Pilot Randomized, Double-Blinded, Placebo-Controlled Clinical Trial” (Galen Medical Journal, 2019)
  • “COVID-19 Reinfection Rate and Related Risk Factors in Fars Province, Iran: A Retrospective Cohort Study” (Iranian Journal of Medical Sciences, 2023)
  • “Efficacy of Plantago major leaf extract cream in preventing acute radiodermatitis in breast cancer patients: A randomized clinical trial” (European Journal of Integrative Medicine, 2023)

🏆Accolades and Recognition :

Dr. Tavakoli’s excellence has been recognized through various awards and honors. He was the top student in the Traditional Persian Medicine Ph.D. comprehensive exam at Shiraz University of Medical Sciences in 2014 and the top Ph.D. graduate in 2012. In 2010, he was awarded as the Annual Best Staff at Shiraz University of Medical Sciences, reflecting his outstanding contributions to the institution.

🌟Impact and Influence :

Dr. Tavakoli has had a profound impact on both his students and the broader medical community. His leadership roles, such as being a member of the Executive Committee of the Shiraz International mHealth Congress and his involvement with the Iranian Scientific Association of Traditional Medicine, have allowed him to influence the direction of medical research and public health policies.

🌍Legacy and Future Contributions :

Dr. Tavakoli’s legacy is characterized by his commitment to integrating traditional Persian medicine with contemporary clinical practices. His work has paved the way for future research in this field, promoting a holistic approach to healthcare. His ongoing research and publications continue to influence and inspire new generations of medical professionals.

In the future, Dr. Tavakoli aims to expand his research into the global applications of traditional Persian medicine, contributing to international medical knowledge and practices. His dedication to education, research, and public health ensures that his contributions will have a lasting impact on the medical community and beyond.

🎓Publication 

Reporting of adverse effects of pomegranate in clinical studies: a systematic review

  • Authors   :Hamid Zare, Ehsan Amiri Ardekani, Ali Tavakoli, Ryan Bradley, Fatemeh Tavakoli, Mehdi Pasalar
  • Journal    :Journal of Complementary and Integrative Medicine
  • Year         : 2024

Radiodermatitis in the field of traditional Persian medicine; a narrative review

    • Authors :Ghazaleh Heydarirad, Bahareh Ahadi, Ali Tavakoli, Hamid Reza Mirzaei, Mojgan Mehri Ardestani, Shaghayegh Kamian, Mehdi Pasalar
    • Journal   :Annals of the Romanian Society for Cell Biology
    • Year       : 2021

World Congress Integrative Medicine & Health 2017: part two: Berlin, Germany. 3–5 May 2017

  • Authors  :, Kyung-Eun Choi, Lisha He, Han Wang, X He, C Gu, Y Zhang, Linhua Zhao, Xiaolin Tong, Lisha He, Han Wang, Xinhui He, Chengjuan Gu, Ying Zhang, Linhua Zhao, Xiaolin Tong, Lisha He
  • Journal    :BMC Complementary and Alternative Medicine
  • Year         :  2017

Efficacy of Plantago major leaf extract cream compared to placebo in preventing acute radiodermatitis in breast cancer patients: A randomized clinical trial

  • Authors  :Zahra Salehi, Ali Tavakoli, Seyed Hassan Hamedi, Soodabeh Samimi, Foroogh Namjooyan, Mansour Ansari, Hamid Nasrollahi, Nezhat Khanjani, Niloofar Ahmadloo, Ahmad Mosalaei, Behnam Kadkhodaei, Hossein Molavi Vardanjani, Mehrab Sayadi
  • Journal   :European Journal of Integrative Medicine
  • Year        :   2023

 

Impact of Jollab on Blood Parameters in Patients with Breast Cancer Undergoing Chemotherapy: A Pilot Randomized Controlled Trial

  • Authors  :Ghazaleh Heydarirad Ahadi, Bahareh Ahadi, Mehdi Pasalar, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Ali TavakoliGhazaleh Heydarirad Ahadi, Bahareh Ahadi, Mehdi Pasalar, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Ali Tavakoli
  • Journal   :Galen Medical Journal
  • Year        :   2021

Prof . Helen Hughes|Drying technologies|Best Researcher Award

Published on by Top Pharmaceutical

Prof . Helen Hughes,Drying technologies,Best Researcher Award

Prof . Helen Hughes, at South East Technological University,Ireland

PROFILE

Orcid

🎓Early Academic Pursuits :

Prof. Helen Hughes began her academic journey with a B.Sc. in Analytical Science from Dublin City University (DCU), graduating with a 2.1 in 1990. She continued her studies at DCU, earning a Ph.D. in 1993. In 1994, she completed a Quality Auditor certification from Shannon Quality Training, further enhancing her expertise in quality management.

💼Professional Endeavors :

Prof. Hughes’s professional career is marked by a series of impactful roles across academia and industry. She started as an Analyst at Squibb-Linson Ltd. and Schering-Plough Ltd., gaining hands-on experience in the pharmaceutical industry. She then served as a Q.A. Manager at Waterford Foods from 1993 to 1994 and a Research Analyst at Gerard Laboratories in 1994. Since 1994, Prof. Hughes has been a dedicated lecturer at Waterford Institute of Technology (WIT), now South East Technological University (SETU). Her teaching portfolio includes courses in Quality Management and Inorganic Chemistry, and she has been actively involved in course development and industry liaison for the BSc (Hons) Pharmaceutical Science program.

🔬Contributions and Research Focus :

Prof. Hughes’s research contributions span various domains, including quality management, molecular imprinted polymers, and drug delivery systems. She has supervised 21 Ph.D. and 2 MSc students to completion and currently mentors seven Ph.D. students. Prof. Hughes has secured over €12 million in competitive research funding and published 52 peer-reviewed articles, a book chapter, and 74 conference proceedings, amassing 2,358 citations and an H-index of 25.

As a founding member of the Pharmaceutical and Molecular Biotechnology Research Centre (PMBRC) and the Eco-Innovation Research Centre (EIRC) at WIT, Prof. Hughes has significantly advanced research in biopharmaceuticals and eco-innovation. Her current research includes leading the (bio)pharmaceutical sub-group for developing the MPharm pharmacy program at SETU and organizing the national environmental conference, Environ 2024.

🏅Accolades and Recognition :

Prof. Hughes’s excellence in research and education has been recognized through various awards and honors. She received the WIT annual award for excellence in postgraduate research supervision in 2009. Additionally, she has served as an expert reviewer for high-impact journals and funding agencies and participated in national panels, such as the review of all IRCSET applications in 2012. Her course leadership of the BSc (Hons) Pharmaceutical Science program earned the Pharma Industry Education and Training awards in 2017 and 2022.

🌍Impact and Influence :

Prof. Hughes’s influence extends beyond her research and teaching. She has collaborated extensively with national and international organizations, contributing to industry and academia. Her leadership roles in professional bodies, such as EURACHEM and Excellence Ireland, highlight her commitment to advancing analytical measurement and quality management. Prof. Hughes has also played a pivotal role in mentoring and guiding postgraduate students and staff, fostering a collaborative research environment.

🌟Legacy and Future Contributions :

Prof. Hughes’s legacy is marked by her dedication to research, education, and community engagement. She has left an indelible mark on the academic and scientific communities through her extensive research funding, publications, and student mentorship. Her future contributions are expected to continue influencing the fields of pharmaceutical science and eco-innovation, driven by her ongoing research and leadership in program development.

 

🎓Publication 

Phosphate removal from wastewater using scallop and whelk shells

  • Authors   :Egbedi Brakemi; Kinsella Michael; Shiau Pin Tan; Hughes Helen
  • Journal    :Water Process Engineering
  • Year         : 2023

Evaluation and Screening of Biopharmaceuticals using Multi-Angle Dynamic Light Scattering

    • Authors :Jason Beirne; Dikshitkumar Khamar; Ciaran Maguire; Ambrose Hayden; Helen Hughes
    • Journal   :PharmSciTech
    • Year       : 2023

Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan

  • Authors  :Niall J. O’Reilly; Anuj Chauhan; Laurence Fitzhenry; Helen Hughesf
  • Journal    :Pharmaceutics
  • Year         :  2021

Penetration Enhancers for Topical Drug Delivery to the Ocular Posterior Segment—A Systematic Review

  • Authors  :Abhinav Thareja; Helen Hughes; Carmen Alvarez-Lorenzo; Jenni J. Hakkarainen; Zubair Ahmed
  • Journal   :Pharmaceutics
  • Year        :   2021

 

Dissolving microneedle based transdermal delivery of therapeutic peptide analogues

  • Authors  :Hughes, H.; O’Reilly, N.J.; Allender, C.J.; Barrow, D.A.; McLoughlin, P.
  • Journal   :pharmaceutics
  • Year        :   2019

Mr. Mahmoud Mansour| Drug analysis|Best Researcher Award

Published on by Top Pharmaceutical

Mr. Mahmoud Mansour,Drug analysis,Best Researcher Award

Mr. Mahmoud Mansour, at King Saud bin Abdulaziz University for health Sciences,saudi Arabia

PROFILE

Google scholar
Scopus

🎓Education :

  • PhD in Biochemistry (Leukotrienes and Lipoxins: Bioactive Mediators)
    • Institution: Karolinska Institutet, Stockholm, Sweden
    • Years: 1990-1993
    • Thesis: Role of Leukotrienes C4 and B4 in chronic myeloid leukemia: Specificity of interaction with GM-CSF
  • Master’s Degree in Biochemistry
    • Institution: Al-Azhar University, Cairo, Egypt
    • Years: 1987-1990
    • Thesis: Female sex steroids and peptide hormones in breast cancer in relation to estrogen receptor
  • Diploma in Biochemical Analysis
    • Institution: Al-Azhar University, Cairo, Egypt
    • Years: 1985-1986
    • Grade: Very Good
  • Bachelor of Pharmaceutical Sciences
    • Institution: Al-Azhar University, Cairo, Egypt
    • Years: 1978-1984
    • Grade: Excellent with Honors

🏅Management Experience :

  • Head, Tumor Markers Oncology Research Unit
    • Department: Biochemistry, Al-Azhar University
    • Years: 09/2002 – 08/2005

🏆 Honors & Awards :

  • Travel Award to the International Pharmaceutical Students Federation Conference, Lausanne, Switzerland (1983)
  • State Encouragement Award in Medical Sciences (1998)

🔬 Research Interests :

  • Leukotrienes and lipoxins, oxidative damage, tumor markers, molecular biology, and cancer treatment methodologies.

 

🎓Publication 

Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT‐diaphorase in different tissues of mice: a possible mechanism of action

  • Authors   :Mahmoud A Mansour, Mahmoud N Nagi, Aiman S El‐Khatib, Abdullah M Al‐Bekairi
  • Journal    :Cell biochemistry and function
  • Year         : 2002

Protective effect of thymoquinone against doxorubicin–induced cardiotoxicity in rats: A possible mechanism of protection

    • Authors :Mahmoud N Nagi, Mahmoud A Mansour
    • Journal   :Pharmacological research
    • Year       : 2000

Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone

  • Authors  :Mahmoud Ahmed Mansour, OT Ginawi, T El-Hadiyah, AS El-Khatib, OA Al-Shabanah, HA Al-Sawaf
  • Journal    :Research communications in molecular pathology and pharmacology,
  • Year         :  2001

Protective effects of thymoquinone and desferrioxamine against hepatotoxicity of carbon tetrachloride in mice

  • Authors  :Mahmoud A Mansour
  • Journal   :Life sciences
  • Year        :   2000

 

Inhibition of 5-lipoxygenase and Leukotriene C4 Synthase in Human Blood Cells by Thymoquinone

  • Authors  :Mahmoud Mansour, Susanne Tornhamre
  • Journal   :enzyme inhibition and medicinal chemistry
  • Year        :   2004

Assist Prof Dr. Ahmed Srag el-din| Nanotechnology|Best Researcher Award

Published on by Top Pharmaceutical

Assist Prof Dr. Ahmed Srag el-din,Nanotechnology,Best Researcher Award

Assist Prof Dr. Ahmed Srag el-din, at Delta university for science and technology,Egypt

PROFILE

Orcid
Scopus

Early Academic Pursuits 🎓

Dr. Ahmed SG Srag El-Din embarked on his academic journey with a focus on pharmaceutical sciences. His early academic pursuits were marked by a deep interest in drug delivery systems and nanotechnology. He began his higher education with a Bachelor’s degree in Pharmacy, where he developed a strong foundation in pharmaceutical sciences. Driven by a passion for research and innovation, he pursued advanced degrees, leading to a robust understanding of drug formulation and delivery mechanisms. This academic groundwork set the stage for his future contributions to the field.

Professional Endeavors 🏆

Dr. El-Din’s professional career has been characterized by a commitment to advancing pharmaceutical science and drug delivery technologies. He has held various positions that allowed him to leverage his expertise in pharmaceutical research and development. His professional trajectory includes roles in academia, where he has been involved in teaching and mentoring the next generation of pharmaceutical scientists. His work has not only contributed to the academic community but also to practical applications in drug delivery systems.

Contributions and Research Focus 🔬

Dr. El-Din’s research has significantly impacted the field of pharmaceutical sciences, particularly in the development and evaluation of novel drug delivery systems. His contributions include:

  1. Self-Nanoemulsifying Drug Delivery Systems: He has developed and evaluated self-nanoemulsifying drug delivery systems for sinapic acid, enhancing its antiviral efficacy against SARS-CoV2. This research has potential implications for the treatment of viral infections, demonstrating his innovative approach to drug delivery.
  2. Nanoparticle-Based Drug Delivery: His work on azithromycin-loaded chitosan nanoparticles and starch nanoparticles for enhancing oral bioavailability of drugs highlights his focus on improving drug delivery efficiency and therapeutic outcomes.
  3. Transdermal Delivery Systems: Dr. El-Din has explored novel transdermal delivery systems, including thermosensitive gels and nanoethosomal gels, to improve the absorption and efficacy of medications such as betahistine dihydrochloride.
  4. Antitumor and Anticancer Therapeutics: His research includes the optimization of PLGA nanoparticles for delivering novel anticancer peptides and the development of particulate delivery systems for antitumor therapeutics.

Accolades and Recognition 🏅

Dr. El-Din has been recognized for his contributions to pharmaceutical research through various accolades and honors. His work has been published in reputable journals, including:

  • Pharmaceutics: A prominent paper on self-nanoemulsifying drug delivery systems for sinapic acid.
  • Drug Design, Development and Therapy: Notable for research on starch nanoparticles and their pharmaceutical applications.
  • Journal of Drug Delivery Science and Technology: Published a significant study on selenium nanoparticles and their therapeutic potential.

These publications reflect his commitment to advancing pharmaceutical science and his recognition as a leading researcher in the field.

Impact and Influence 🌟

Dr. El-Din’s research has had a substantial impact on both academic and practical aspects of pharmaceutical science. His work on novel drug delivery systems has influenced the development of more effective and efficient therapeutic formulations. The innovative approaches he has introduced in drug delivery technologies have potential applications in various therapeutic areas, including antiviral treatments, cancer therapy, and transdermal drug delivery.

His influence extends to the academic community through his role in teaching and mentoring students, contributing to the next generation of pharmaceutical scientists.

Legacy and Future Contributions 🔮

Dr. El-Din’s legacy in pharmaceutical science is marked by his pioneering research and contributions to drug delivery systems. His innovative work has laid the groundwork for future advancements in the field, and his research continues to inspire new approaches to drug formulation and delivery.

🎓Publication 

Selenium nanoparticle ameliorates LPS-induced acute lung injury in rats through inhibition of ferroptosis, inflammation, and HSPs

Development and Evaluation of a Self-Nanoemulsifying Drug Delivery System for Sinapic Acid with Improved Antiviral Efficacy against SARS-CoV-2

    • Authors :Alhadrami, H.A., El-Din, A.S.G.S., Hassan, H.M., … Rateb, M.E., Naguib, D.M.
    • Journal   :Pharmaceutics
    • Year       : 2023

Physicochemical characterization of novel particulate delivery systems for antitumor/metastatic therapeutics

Starch nanoparticles preparation and characterization by in situ combination of sono-precipitation and alkali hydrolysis under ambient temperature

  • Authors  :Gardouh, A.R., El-Din, A.S.G.S., Mostafa, Y., Gad, S.
  • Journal   :Pharmacy and Technology
  • Year        :   2021

 

Optimization of plga nanoparticles for delivery of novel anticancer ck-10 peptide

  • Authors  :Samuel, G., Nazim, U., El-Din, A.S.G.S.
  • Journal   :pharmacy and Technology
  • Year        :   2021